Drug intelligence / Profile preview

Keratinase PB333

Development stage
Unknown
Lead developer
Proteos Biotech
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Topical, Subcutaneous, Intradermal
01

Overview

Keratinase PB333 is a recombinant proteolytic enzyme developed by Proteos Biotech for use in aesthetic medicine and dermatology. Produced through recombinant biotechnology, this enzyme specifically targets and degrades keratin and keratinized proteins within the skin tissue. Its primary mechanism involves the selective proteolysis of the keratinized layer of the stratum corneum, which promotes skin renewal, improves texture, and enhances the permeability of the skin for other active ingredients. It is clinically utilized for a variety of indications, including the treatment of striae (stretch marks), scars, and postsurgical fibrosis, as well as for facial, periocular, and hand rejuvenation. By breaking down abnormal or excessive keratinization, Keratinase PB333 facilitates tissue remodeling and skin health restoration.

Brand names
pbserumSmartker
Other names
Recombinant Keratinase PB333Keratinase
02

Targets

KRT (Keratin, type I cuticular Ha7)

Beyond the preview

Go deeper on Keratinase PB333.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratinase PB333.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call